Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Australia’s credit and charge card payments to near $300 billion in 2025 amid consumer and e-commerce growth, forecasts GlobalData

Australia’s credit and charge card payments market continues to demonstrate resilience and growth, underpinned by rising consumer spending, robust payment infrastructure, and an expanding e-commerce landscape. Enhanced by value-added incentives such as cashback offers, flexible repayment options, and installment facilities, the market is set to maintain an upward trajectory, reaching AUD453.9 billion ($299.7 billion) in […]
Read more

US diagnostic imaging market faces tariff-driven supply chain and capital risks, reveals GlobalData

The US diagnostic imaging (DI) market is facing growing pressure as new US tariffs raise procurement risks and threaten supply chains. With high-value systems like computed tomography (CT) and magnetic resonance imaging (MRI) heavily reliant on global production, hospitals may delay capital spending amid uncertainty. Although domestic manufacturing offers some short-term protection, extended trade tensions […]
Read more

Saudi Arabia card payments to surpass $160 billion in 2025 amid digital shift and policy push, forecasts GlobalData

Saudi Arabia’s card payments market is projected to reach SAR615.5 billion ($164.1 billion) in 2025, driven by a growing shift toward digital transactions and declining cash usage. Strong government support, improved payment infrastructure, and increasing consumer preference for contactless and electronic payments are accelerating this transition, reinforcing the Kingdom’s broader goals of financial inclusion and […]
Read more

Biopharma venture financing declines 20.2% YoY in Q1 2025 amid persistent investor caution, reveals GlobalData

Biopharmaceutical drug company venture financing witnessed a year-on-year (YoY) 20.2% downturn from $8.1 billion during the first quarter (Q1) of 2024 to $6.5 billion in Q1 2025. This suggests that the biopharmaceutical venture financing environment remains challenging, mirroring a similar downturn seen in 2022 and 2023, with investors continuing to favor later-stage companies with clinical […]
Read more

Kubernetes complexity drives surge in demand for enhanced observability tools, says GlobalData

As Kubernetes deployments become more complex, enterprises are intensifying their search for streamlined observability tools to support application modernization efforts. The growing volume of containerized workloads is driving up demand for greater visibility across DevOps teams. In response, the industry is delivering next-generation solutions, featuring intuitive dashboards, AI-driven insights, and open-source innovations to help reduce […]
Read more

Shionogi’s cefiderocol shows improved outcomes with early use in treating gram-negative infections, reports GlobalData

Japan-based Shionogi has shared new real-world evidence showing its antibiotic cefiderocol leads to better outcomes when used early to treat serious gram-negative bacterial infections. Presented at European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 conference in Vienna, the Retrospective Cefiderocol Chart Review (PROVE) study found that earlier use of cefiderocol, rather than […]
Read more

UAE card payments to surpass $150 billion in 2025 amid push for cashless economy, forecasts GlobalData

The UAE’s card payments market is set to grow by 10.6% in 2025 to AED565.5 billion ($154 billion), reflecting a clear shift towards electronic payments. Driven by rising consumer preference for digital transactions and strong government support for financial inclusion, this trend signals the country’s steady move towards a cashless economy amid broader digital transformation […]
Read more

Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals GlobalData

Physician attitudes toward patient choice between the use of biologics and biosimilars vary widely across global markets, revealing deep-rooted cultural and systemic differences. While nearly half of (49%) physicians support patient involvement in treatment decisions, enthusiasm ranges from strong backing in China to notable skepticism in Germany and France—underscoring the growing but uneven shift toward […]
Read more

Davis Polk & Wardwell and Kirkland & Ellis top M&A legal advisers in retail sector during Q1 2025, reveals GlobalData

Davis Polk & Wardwell and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the retail sector during the first quarter (Q1) of 2025 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database […]
Read more

Wachtell, Lipton, Rosen & Katz and Paul, Weiss, Rifkind, Wharton & Garrison top M&A legal advisers in construction sector during Q1 2025, reveals GlobalData

Wachtell, Lipton, Rosen & Katz and Paul, Weiss, Rifkind, Wharton & Garrison were the top mergers and acquisitions (M&A) legal advisers in the construction sector during the first quarter (Q1) of 2025 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis […]
Read more

Trump’s semiconductor tariffs threaten to affect US medical device industry growth, says GlobalData

Donald Trump’s proposed semiconductor tariffs could pose a serious threat to the growth of the US medical device industry, as over half of all devices depend on semiconductors (chips) to operate. With global supply chains under strain and costs rising, especially from Taiwan-based suppliers, the healthcare sector faces looming price increases that may hinder accessibility […]
Read more
1 … 28 29 30 31 32 … 206